BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20439916)

  • 1. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
    Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
    J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
    Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
    Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.
    Qian J; Yi H; Guo C; Yu X; Zuo D; Chen X; Kane JM; Repasky EA; Subjeck JR; Wang XY
    J Immunol; 2011 Sep; 187(6):2905-14. PubMed ID: 21832164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.
    Wang XY; Kazim L; Repasky EA; Subjeck JR
    J Immunol; 2001 Jan; 166(1):490-7. PubMed ID: 11123328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.
    Guo C; Subjeck JR; Wang XY
    Methods Mol Biol; 2018; 1709():345-357. PubMed ID: 29177671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma.
    Wang XY; Arnouk H; Chen X; Kazim L; Repasky EA; Subjeck JR
    J Immunol; 2006 Aug; 177(3):1543-51. PubMed ID: 16849461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
    Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
    Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing antigen cross-presentation and T-cell priming by complexing protein antigen to recombinant large heat-shock protein.
    Wang XY; Yi H; Yu X; Zuo D; Subjeck JR
    Methods Mol Biol; 2011; 787():277-87. PubMed ID: 21898243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I.
    Facciponte JG; Wang XY; Subjeck JR
    Eur J Immunol; 2007 Aug; 37(8):2268-79. PubMed ID: 17615582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 110 improves the antitumor effects of the cytotoxic T lymphocyte epitope E7(49-57) in mice.
    Ren F; Xu Y; Mao L; Ou R; Ding Z; Zhang X; Tang J; Li B; Jia Z; Tian Z; Ni B; Wu Y
    Cancer Biol Ther; 2010 Jan; 9(2):134-41. PubMed ID: 19901562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo.
    Arnouk H; Zynda ER; Wang XY; Hylander BL; Manjili MH; Repasky EA; Subjeck JR; Latif Kazim A
    Int J Hyperthermia; 2010; 26(4):366-75. PubMed ID: 20210603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
    Wang XY; Kazim L; Repasky EA; Subjeck JR
    Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum chaperone glucose regulated protein 170-Pokemon complexes elicit a robust antitumor immune response in vivo.
    Yuan B; Xian R; Wu X; Jing J; Chen K; Liu G; Zhou Z
    Immunobiology; 2012 Jul; 217(7):738-42. PubMed ID: 22317751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity.
    Park JE; Facciponte J; Chen X; MacDonald I; Repasky EA; Manjili MH; Wang XY; Subjeck JR
    Cancer Res; 2006 Jan; 66(2):1161-8. PubMed ID: 16424054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model.
    McWilliams JA; McGurran SM; Dow SW; Slansky JE; Kedl RM
    J Immunol; 2006 Jul; 177(1):155-61. PubMed ID: 16785510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.
    Manjili MH; Henderson R; Wang XY; Chen X; Li Y; Repasky E; Kazim L; Subjeck JR
    Cancer Res; 2002 Mar; 62(6):1737-42. PubMed ID: 11912148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
    Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
    J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a chaperone complex based on PSCA and GRP170 adjuvant enhances the CTL response and inhibits the tumor growth in mice.
    Huo W; Ye J; Liu R; Chen J; Li Q
    Vaccine; 2010 Aug; 28(38):6333-7. PubMed ID: 20637304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.
    Reynolds SR; Celis E; Sette A; Oratz R; Shapiro RL; Johnston D; Fotino M; Bystryn JC
    J Immunol; 1998 Dec; 161(12):6970-6. PubMed ID: 9862732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.